
    
      This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced Magnetic
      Resonance Angiography (CE-MRA) of arteries (specified vessel segments) by analyzing the rate
      of agreement, image quality, and diagnostic confidence between a CE-MRA based diagnosis and
      the diagnosis achieved from the comparator procedure IA DSA using Ultravist.
    
  